Abstract. Human papillomavirus (HPV) type 31 is an important pathogenic subtype associated with cervical cancer. The aims of the present study were to analyze E5, E6, E7 and L1 gene mutations of HPV-31 among females, and to elucidate the evolutionary associations between them. In total, 87 positive samples were collected. The E5, E6, E7 and L1 genes were amplified by polymerase chain reaction and sequenced. Subsequently, two phylogenetic trees were constructed from the nucleotide sequences of the E5, E6 and E7 and the L1 variants of HPV-31. In total, 31 mutation sites of E5, E6 and E7 genes were identified, of which 16 were non-synonymous. T4053A (F80I), C285T (H60Y), C520T (A138V) and A743G (K62E) were the most common non-synonymous mutations. A total of 30 mutation sites of L1 genes were identified, of which four were non-synonymous. The most common non-synonymous mutations of L1 genes were A6350G (T29A) and C6372A (T36N). By phylogenetic analysis, A and C variants were most frequently detected, while B variants were less frequently detected in this population. The sequence variation data obtained in the present study provides a foundation for future research regarding HPV-induced oncogenesis, and may prove valuable for developing diagnostic probes and in the design of HPV vaccines for targeted populations.
Introduction
Cervical cancer is a common form of tumorigenesis among females globally. The most important risk factor for cervical cancer is persistent infection with human papillomavirus (HPV) (1) . HPVs with <90% nucleotide sequence homology in the L1 gene are considered different species (traditionally referred to as 'types'), HPVs with 90-98% L1 sequence homology are different subtypes and HPVs with >98% L1 sequence homology are considered mutants of the same subtype (2, 3) . Over 150 HPV types have been identified, of which 60 types are predominantly detected in the genital tract (2, 3) . HPV types are divided into high risk 18, 31, 33, 35, 39, 45 , 51, 52, 53, 56, 58, 59, 66, 68, 73 and 83) and low risk (HPV-6, 11, 40, 42, 43, 44, 54, 61, 70, 72 and 81) according to their oncogenic potential. Low risk HPV causes mild genital warts and no oncogenic risk. The majority of high risk (HR) types, including 16, 18, 31, 33, 52 and 58, have the potential to lead to invasive cervical cancer (4) (5) (6) .
When the HPV DNA integrates it inactivates tumorsuppressor genes, stimulating oncogene expression (7, 8) . The E7 protein of HR HPV binds to and inactivates retinoblastoma protein (pRB), a tumor suppressor protein (9, 10) . E6 protein has been demonstrated to mediate the degradation of p53 through the E6-associated protein (9, 11) . High protein expression levels of epidermal growth factor receptor and erb-b2 receptor tyrosine kinase 4 are promoted by the E5 protein, which has also been demonstrated to promote cell proliferation and signal transmission (12, 13) .
The study of HPV variants is on the increase, and multiple reports have confirmed that HPV variants differ in biology and etiology (14) . At present, multiple studies have investigated HPV-16, 18, 52 and 58 variants, however the HPV-31 variant, which is the one of the HR oncogenic types, has been rarely studied, particularly in China. Due to the differences in biological characteristics, it is necessary to identify the HPV-31 variants (15) . The results of the present study may provide an effective reference for further clinical application, and may aid assessment of the prognosis of patients with HPV.
The distribution of HPV subtypes differs geographically and across populations, and the primary aim of the present study was to assess the single nucleotide polymorphisms 
Materials and methods
Ethical statement. The present study was approved by the Ethics Committee of Sichuan University (Chengdu, China). All participants provided informed consent prior to the collection of experimental specimens. DNA extraction. DNA was extracted using the Human Papillomavirus Genotyping kit for 23 Types (PCR-RDB; Yaneng Bio-Technology (Shenzhen) Co., Ltd., Shenzhen, China) according to the manufacturer's protocols. The cervical specimens, which were stored at -20˚C, were thawed to room temperature. Cells were suspended in Cell Preservation Liquid and 1 ml suspension transferred to a 1.5 ml Eppendorf tube (Shanghai Sangon Biological Engineering Technology and Services Co., Ltd., Shanghai, China) and subjected to centrifugation for 10 min at 16,155 x g at 4-6˚C in a Hema 14D high speed centrifuge. The supernatant was removed and 100 µl cell pyrolysis liquid (KCl, Tris-HCl, Triton X-100) was added to the sediment, which was incubated in a boiling water bath for 10 min. Centrifugation was conducted again, at 16,155 x g for 10 min at 4-6˚C, and the supernatant was removed. The supernatant was stored at 4˚C and used for polymerase chain reaction (PCR) analysis. All of the extracted DNA samples were stored at -20˚C until examination. None of the samples remained at room temperature for more than 2 h, or at 4˚C for more than 24 h, to avoid DNA degradation. 
Data analysis.
Following direct sequencing, all sequences were aligned with an HPV-31 prototype sequence (GenBank accession no. J04353) available from the National Center for Biotechnology Information (NCBI). The samples with mutational sites were amplified and sequenced again to rule out the possibility of error due to mismatched bases in the PCR process. All E5, E6, E7 and L1 sequences were separately aligned by Clustal X 2.1 (ftp://ftp.ebi.ac.uk/pub/ software/clustalw2/) (16) . Maximum-likelihood phylogenetic trees of respective HPV-31 E5, E6, E7 and L1 variation patterns were subsequently constructed by Molecular Evolutionary Genetics Analysis 6 software (17), using Kimura's two-parameter model (18) . To estimate the selection pressure acting on the HPV-31 E5, E6, E7 and L1 gene sequences, non-synonymous and synonymous nucleotide divergence for coding regions was inferred by the Nei and Gojobori method with Phylogenetic Analyses by Maximum Likelihood (PAML; http://abacus.gene.ucl.ac.uk/software/paml.html) software version 4.8 (19) (20) (21) (22) .
Nucleotide sequence accession numbers. All sequences of the E5, E6, E7 and L1 genes were submitted to the NCBI GenBank database and assigned accession numbers. The HPV-31 E5, E6 and E7 sequences, 31EPL01-31EPL16, were published with the GenBank accession codes KU163553-KU163568. The HPV-31 L1 sequences, 31LPL01-31LPL16 are published with the GenBank accession codes KU163569-KU163575, KU163584 and KU163576-KU163583. Variation of E5 at nucleotide position Category  3827  3828  3956  3957  3980  3981  4005  4052  4053  4059  4064  n Reference nt
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Nucleotide positions are shown where sequence alterations were detected in comparison with the sequence of the reference HPV-31 isolate (GenBank accession no. J04353). Nucleotide changes are presented by the corresponding letters. Dashes indicate no nucleotide exchange from the HPV-31 reference sequence. The number of amino acid mutation is the location in the corresponding genes. HPV, human papillomavirus; nt, nucleotide; AA, amino acid.
E5 sequence variations.
In total, 141 HPV-31 positive samples were detected, of which 87 samples were used for further exploration; 54 samples were excluded due to incomplete data. In the present study, sequences of HPV-31 E5, E6, E7 genes and the L1 gene were obtained from 48/87 and 37/87 patients, respectively. The failure of some genes to be amplified or sequenced was due to either a short copy of HPV or instability of the amplicon. Compared with the HPV-31 reference sequence (J04353), 11 nucleotide variations of the E5 gene were observed in the 48 HPV-31 E5 sequences studied (Table II) . In total, six missense mutations of A3828G (1/48), A3957G (15/48), C3981G (1/48), G4005A (1/48), T4053A (42/48) and A4059G (3/48) were revealed, which resulted in amino acid changes of N5D, I48V, P56A, V64I, F80I and S82G, respectively (Table II) . The remaining five variations, A3827G (15/48), G3956A (17/48), T3980A (11/48), T4052C (16/48) and A4064G (1/48), were synonymous variations. T4053A was the most common non-synonymous variation, followed by A3957G. Excluding A4064G, which had only one specimen, the synonymous mutations were of similar quantity.
E6 sequence variations.
The present study detected 14 mutation sites in the E6 gene in 34/48 (70.8%) samples through comparative analysis with the HPV-31 reference sequence (J04353). No variations were observed in 14/48 (29.2%) samples, which were referred to as 'E6 prototype-like' sequences. There were six non-synonymous variations: C285T (15/48), A297G (2/48), A301G (1/48), T312C (2/48), A475G (2/48) and C520T (17/48), which led to amino acids changes of H60Y, T64A, K65R, T69L, K123R and A138V (Table III) . The frequencies of C285T (15/48) and C520T (17/48) mutations were 15/48 (31.3%) and 17/48 (35.4%), respectively. These resulted in changes at the same point in the genetic code, however expressed different amino acids. The remaining eight mutations were synonymous (Table III) .
E7 sequence variations.
Compared with the HPV-31 reference sequence (J04353), six mutation sites were presented in the 48 samples (Table IV) . There were four non-synonymous variations: C626T (33/48), G695A (15/48), A743G (47/48) and C737G (1/48) which resulted in amino acid changes of H23Y, E46K, K62E and Q60E (Table IV) . A743G was the most common non-synonymous mutation across all specimens. The remaining two mutations were G580A (15/48) and C670T (15/48), and were synonymous.
The specimens were divided into 16 species, termed 31EPL01-31EPL16 (Tables II, III and IV) . According to the frequency of E5, E6 and E7 mutations, based on the statistics from the present study, 31 mutation sites were detected, Category  134 176  248  285 297 301 312  321 326  335 404  428 475  520  n Reference nt
Nucleotide positions are shown where sequence alterations were detected in comparison with the sequence of the reference HPV-31 isolate (GenBank accession number J04353). Nucleotide changes are presented by the corresponding letters. Dashes indicate no nucleotide exchange from the HPV-31 reference sequence. The number of amino acid mutation is the location in the corresponding genes. HPV, human papillomavirus; nt, nucleotide; AA, amino acid.
of which 16 sites were non-synonymous mutations and the remaining 15 were synonymous mutations. Phylogenetic trees of respective HPV-31 E5, E6 and E7 variation patterns were subsequently constructed by Molecular Evolutionary Genetics Analysis 6 software (17), using Kimura's two-parameter model (18) . Phylogenetic analysis of HPV-31 variant lineage distribution (n=48) in Sichuan, China (23) , demonstrated that A variants were most commonly detected (66.7%; Fig. 1 ), followed by C variants (31.3%; Fig. 1 ) and B variants (2.0%; Fig. 1 ).
L1 sequence variations.
Compared with the HPV-31 reference sequence (J04353), the specimens were divided into 16 species, named 31LPL01-31LPL16 (Tables V and VI) . In total, 30 nucleotide variations of the L1 gene were observed in strains from 37 patients, of which four were missense mutations: T6131A (1/37), A6350G (14/37), C6372A (17/37) and A6840G (1/37), which resulted in amino acid changes of S206T, T29A, T36N and Q192R, respectively (Table III) . The remaining 26 variations were synonymous, of which C6367T (37/37) and C6817A (37/37) were detected in samples. The non-synonymous mutations A6350G (14/37) and C6372A (17/37) were more common than the others. No nucleotide substitutions resulting in premature termination codon or frameshift mutations were detected.
Phylogenetic trees of respective HPV-31 L1 variation patterns were subsequently constructed by Molecular Evolutionary Genetics Analysis 6 software (17), using Kimura's two-parameter model (18) . Phylogenetic analysis of HPV-31 variant lineage distribution (n=37) in Sichuan, China, revealed that A variants were most commonly detected (54.0%; Fig. 2) , followed by C variants (37.8%; Fig. 2 ), and B variant (8.2%; Fig. 2 ).
Selective pressure analysis of all sequences. PAML 4.8 software was used to test for variable dN/dS rate ratios among the lineages. There was no evidence of negative selection in the sequence alignment of HPV-31 E5, E6 and E7 genes or L1 genes (P>0.05 and P>0.05, respectively; Tables VII and VIII,  respectively) .
Discussion
The present study demonstrated that 31.1% of the females with cervical cancer studied were infected with at least one subtype of HPV. Globally, ~2-20% of healthy females have detectable levels of HPV DNA in their cervical tissue, as detected by epidemiological studies (24) . The higher rate recorded in the present study may reflect the design of the study, which selected only females with active cervical cancer. Previous studies have demonstrated that smoking habits, the number of sexual partners, history of sexually transmitted diseases and abnormal cervical cytology collectively increase the risk of HPV infection (25) .
Knowledge of HPV genetic variants may aid in the understanding of the pathogenic mechanisms and progression of cervical cancer. It has previously been suggested that variants Table IV . Nucleotide sequence mutations of HPV-31 E7. Category  580  626  670  695  743  737  n Reference nt of the same HPV type are biologically distinct and may have different pathogenic risks (26) . HPV-16 is the most frequent HPV type globally, followed by HPV-18 (8) . In Sichuan, China, HPV-16 is also the most frequent, however the second most Figure 1 . Sequences from the present study are labeled with black circles (n=48). Other sequences (n=11) were the variants previously reported in the whole genome study (23) and were used as the standard sequences. Viral lineages analyzed in the present study are clustered into A, B and C branches. Figure 2 . Sequences from the present study are labeled with black circles (n=37). Other sequences (n=11) were the variants previously reported in the whole genome study (23) and were used as the standard sequences. Viral lineages analyzed in the present study are clustered into A, B and C branches.
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frequent is HPV-58 (27) . The incidence of HR HPV types in Sichuan were demonstrated to be as follows: HPV-16 (28.1%), HPV-58 (16.0%), HPV-33 (9.2%), HPV-52 (8.4), HPV-18 (7.3%) and HPV-31 (3.4%), with HPV-18 only being the fifth most common (27) . In the present study, the observed HPV-31 prevalence was 1.1%. This was similar to the prevalence reported by Xi et al (15) , which enrolled 5,060 females from the ASC-US and LSIL Triage study in the US and observed a prevalence of 1.1%. However, this differs from the rate (0.4%) reported by a meta-analysis of females with normal cytology from Asia (28), which was in accordance with an international study that reported that the prevalence of HPV-31 is lower in Asia (0.3%) compared with the global average (0.8%), particularly in European (2.3%) and Latin American (1.2%) females with normal cytology (29) . However, the rate of HPV-31 prevalence in Sichuan, China, differed from the 0.52% previously reported in Northern Chinese females (30) . Future studies regarding geographic variation and ethnic differences may be worthwhile. HPV E5, E6 and E7 proteins are important for replication and transcription of viral DNA, and are involved in interacting with the cytoskeleton network, cell immortalization and transformation (31). E6 and E7 are known for their ability to bind to and inactivate p53 and pRB, respectively, however they also interact with a wide range of cellular proteins (11, 32, 33) .
To the best of our knowledge, the present study was the first to examine gene mutations of HPV-31 E5. All the mutation sites detected by the present study were novel.
Nucleotide changes in the HPV-31 E6 oncogene at positive 134, 301, 312 and 335 were discovered, to the best of our knowledge, for the first time in the present study. When considering the HPV-31 E7 oncogene, a novel nucleotide change at positive 737 was reported by the present study. According to the frequency of E5, E6, E7 gene mutations, the samples were divided into six, nine and five species, respectively. However, when the E5, E6 and E7 sequences of the samples were integrated, 16 species were detected. E5, E6 and E7 oncogenes displayed characteristics of the alternative model, Kimura's two parameter model, suggesting that these mutations may be cyclic in frequency in the Sichuan population. In these genes, the non-synonymous mutations C285T, A297G, A475G, C520T, C626T, G695A, A743G, C737G, A3975G, C3981G, G4005A, T4053A and A4059G can lead to changes to polarity, hydropathic potential and the amino acid side chain, which potentially altered the folding of the oncoprotein (34) .
In the L1 region, one or more amino acid changes may lead to a conformational change of the capsid protein, and interfere with the conformation of epitopes relevant to viral neutralization. A previous study in Central Brazil reported six mutations (34) , fewer than the 30 mutations reported by the present study, of which four were non-synonymous mutations. This previous study reported the presence of the mutation C6862T in Brazil, however the present study did not observe this mutation in Sichuan, China. Variation of L1 at nucleotide position Category  5581 5752 5797 5839 5848 5866 5920 5921 5998 6019 6067 6085 6127 6131 6199 n   Reference nt  T  A  C  T  A  T  A  T  A  A  A  C  A  T  C  31LPL01  ---------------12  31LPL02 A InL, the log-likelihood difference between the two models: 2Δl, twice the log-likelihood difference between the two models; the positively selected sites were identified with posterior probability ≥0.9 using the Bayes empirical Bayes approach. NA, not available. NS, sites under positive selection not reaching the significance level of 0.9. HPV, human papillomavirus. InL, the log-likelihood difference between the two models; 2Δl, twice the log-likelihood difference between the two models; the positively selected sites were identified with posterior probability ≥0.9 using the Bayes empirical Bayes approach. NA, not available; NS, sites under positive selection not reaching the significance level of 0.9; HPV, human papillomavirus. Variation of L1 at nucleotide position Category  6238 6328 6350 6367 6372 6379 6568 6574 6586 6647 6664 6772 6796 6817 6840 n   Reference nt  T  G  A  C  C  A  T  C  T  A  T  G  G  C  A  31LPL01  ---T  ---------A  -T  31LPL02  -A  G  T  A  --T  G  ---A  A  --31LPL03  -A  G  T  A  ---G  -C  -A  A  --31LPL04  -A  G  T  A  ---G  -C  -A  A  --31LPL05  A  --T  A  G  C  ----A  A  A  --31LPL06  A  --T  A  G  C  ----A  A  A  -A  31LPL07 - Xi et al (15) reported the proportion of A, B and C variants were 41.7, 21.1 and 37.2% in the USA female population (28). Chagas et al (35) examined five HPV-31 positive specimens from Brazil and reported that the proportions of A, B and C variants were 57.2, 5.7 and 37.1%, respectively (35) . However, previous investigations have only observed variant lineages A (64.3%) and C (35.7%) in Southern China (30) . As above, in the present study the variant lineage A of HPV-31 was the most commonly detected variant, followed by C. However, the present study also observed the presence of variant lineage B, which has not been previously reported from Southern China. The results of one previous study by Ferenczi et al (36) differ substantially from the above; when 41 HPV-31 positive specimens were collected from Italian females, the proportions of A, B and C variants were 4.9, 29.3 and 65.8%, respectively (36) . Therefore, geographic variation and ethnic differences cannot be ignored.
In conclusion, the present study reported sequence variations in the E5, E6, E7 and L1 genes of HPV-31 isolates from Sichuan, China. The sequence variations in the genes examined may contribute to HPV oncogenesis. These data will provide a solid foundation for further biological and clinical studies, and may also be employed in epidemiological studies where sequence variations are used as markers for monitoring HPV infections in target populations.
